ABCB11 and cholestasis: The AOP on drug-induced cholestasis describes the mechanistic basis of a drug-mediated cholestatic liver injury, starting with a drug-induced triggering factor or molecular initiating event, with a special focus on the inhibition of BSEP as main molecular initiating event [17].